We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$175M
AUM Growth
+$9.44M
Cap. Flow
+$6.42M
Cap. Flow %
3.67%
Top 10 Hldgs %
36.64%
Holding
129
New
19
Increased
30
Reduced
20
Closed
16

Top Buys

Rank Stock Value
1
NLSN
Nielsen Holdings plc
NLSN
+$2.98M
2
BKI
Black Knight, Inc. Common Stock
BKI
+$2.78M
3
VMW
VMware, Inc
VMW
+$2.72M
4
RPTX
Repare Therapeutics
RPTX
+$1.95M
5
COGT icon
Cogent Biosciences
COGT
+$1.63M

Top Sells

Rank Stock Value
1
COHR
Coherent Inc
COHR
+$3.62M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$2.96M
3
GBT
Global Blood Therapeutics, Inc.
GBT
+$2.37M
4
IDYA icon
IDEAYA Biosciences
IDYA
+$1.8M
5
DYN icon
Dyne Therapeutics
DYN
+$1.6M

Sector Composition

Rank Sector Weight
1 Healthcare 46.35%
2 Technology 22.42%
3 Financials 15.33%
4 Communication Services 4.08%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEAM icon
101
Atlassian
TEAM
$39.1B
$248K 0.14%
1,178
– –
EXPE icon
102
Expedia Group
EXPE
$38.5B
$242K 0.14%
2,592
– –
CRM icon
103
Salesforce
CRM
$162B
$241K 0.14%
1,676
– –
LNG icon
104
Cheniere Energy
LNG
$54.8B
$233K 0.13%
+1,406
New +$213K
RIVN icon
105
Rivian
RIVN
$23.7B
$209K 0.12%
+6,364
New +$217K
YOU icon
106
Clear Secure
YOU
$4.97B
$208K 0.12%
+9,100
New +$223K
DDOG icon
107
Datadog
DDOG
$88.6B
$205K 0.12%
2,310
– –
XPO icon
108
XPO
XPO
$23.8B
$203K 0.12%
7,678
– –
DUOL icon
109
Duolingo
DUOL
$6.34B
$200K 0.11%
+2,096
New +$204K
CIXX
110
DELISTED
CI Financial Corp.
CIXX
$198K 0.11%
20,658
– –
BILI icon
111
Bilibili
BILI
$7.53B
$196K 0.11%
12,770
– –
NOAH
112
Noah Holdings
NOAH
$591M
$146K 0.08%
11,116
– –
IQ icon
113
iQIYI
IQ
$1.3B
$102K 0.06%
37,518
– –
ARQT icon
114
Arcutis Biotherapeutics
ARQT
$3.3B
– –
-34,462
Closed -$734K
BBIO icon
115
BridgeBio Pharma
BBIO
$16.4B
– –
-105,942
Closed -$962K
BPMC
116
DELISTED
Blueprint Medicines
BPMC
– –
-12,108
Closed -$612K
CHTR icon
117
Charter Communications
CHTR
$18.8B
– –
-450
Closed -$211K
IDYA icon
118
IDEAYA Biosciences
IDYA
$3.55B
– –
-130,380
Closed -$1.8M
NBP
119
NovaBridge Biosciences American Depositary Shares
NBP
$213M
– –
-26,534
Closed -$300K
ITOS
120
DELISTED
iTeos Therapeutics
ITOS
– –
-18,913
Closed -$390K
KPTI icon
121
Karyopharm Therapeutics
KPTI
$47.6M
– –
-16,692
Closed -$1.13M
KROS icon
122
Keros Therapeutics
KROS
$211M
– –
-16,623
Closed -$459K
KSS icon
123
Kohl's
KSS
$2.1B
– –
-6,106
Closed -$218K
NTRA icon
124
Natera
NTRA
$45.1B
– –
-17,812
Closed -$631K
PTGX icon
125
Protagonist Therapeutics
PTGX
$9.6B
– –
-46,459
Closed -$367K
2 3 4
5
6

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2022 Portfolio in Review

As of Q3 2022, HighVista Strategies held 129 positions worth $175M, up 5.7% from $166M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

HighVista Strategies deployed $6.42M of net new capital in Q3 2022, opening 19 new positions and adding to 30 existing holdings. Its largest new stake was Nielsen Holdings plc: 114,200 shares worth $3.17M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 46% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Dyne Therapeutics, an estimated $1.6M trimmed.

  • HighVista Strategies's largest Q3 2022 buy was Nielsen Holdings plc: 114,200 shares worth $3.17M.
  • HighVista Strategies added most to Repare Therapeutics in Q3 2022, an estimated $1.95M increase.
  • HighVista Strategies's biggest Q3 2022 reduction was Dyne Therapeutics, cutting an estimated $1.6M.
  • HighVista Strategies fully exited Coherent Inc in Q3 2022, selling an estimated $3.62M.
  • HighVista Strategies's ten largest holdings make up 37% of its $175M portfolio in Q3 2022.
  • HighVista Strategies opened 19 new positions and closed 16 in Q3 2022.
  • HighVista Strategies's portfolio value rose 5.7% quarter-over-quarter to $175M.

Based on HighVista Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.